vTv Therapeutics (VTVT) Current Leases (2019 - 2025)
vTv Therapeutics (VTVT) reported Current Leases of $32000.0 for Q3 2025, down 82.32% on a YoY basis from $181000.0 in Q3 2024, and down 59.49% sequentially from $79000.0 in Q2 2025.
vTv Therapeutics (VTVT) Current Leases (2019 - 2025) Analysis & Trends
vTv Therapeutics (VTVT) has 7 years of Current Leases data on file, last reported at $32000.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Leases fell 82.32% year-over-year to $32000.0; the trailing twelve-month figure through Sep 2025 stood at $32000.0 (down 82.32% YoY), and the FY2024 full-year result was $169000.0, changed 0.0% from the prior year.
- Current Leases declined to $32000.0 in Q3 2025, from $79000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $208000.0 in Q3 2022 to a low of $32000.0 in Q3 2025.
- A 5-year average of $159526.3 and a median of $169000.0 in 2021 frame the typical range for Current Leases.
- Across the five-year window, Current Leases rose 19.12% in 2021 and sank 82.32% in 2025, its largest moves.
- Tracing VTVT's Current Leases over 5 years: stood at $184000.0 in 2021, then fell by 16.3% to $154000.0 in 2022, then rose by 9.74% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then sank by 81.07% to $32000.0 in 2025.
- Business Quant data shows VTVT's Current Leases at $32000.0 in Q3 2025, $79000.0 in Q2 2025, and $125000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 177,000.00 |
| Mar 31, 2024 | 173,000.00 |
| Dec 31, 2023 | 169,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 157,000.00 |
| Dec 31, 2022 | 154,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 199,000.00 |
| Mar 31, 2022 | 191,000.00 |
| Dec 31, 2021 | 184,000.00 |
| Sep 30, 2021 | 176,000.00 |
| Jun 30, 2021 | 169,000.00 |
| Mar 31, 2021 | 162,000.00 |
| Dec 31, 2020 | 155,000.00 |